<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04628169</url>
  </required_header>
  <id_info>
    <org_study_id>netrin-1 in placenta accreta</org_study_id>
    <nct_id>NCT04628169</nct_id>
  </id_info>
  <brief_title>Impact of Netrin-1 in the Pathophysiology of Placenta Accreta Spectrum</brief_title>
  <official_title>Impact of Netrin-1 in the Pathophysiology of Placenta Accreta Spectrum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  To shed light on the possible involvement of netrin-1 into the pathophysiology of&#xD;
           placenta accrete spectrum.&#xD;
&#xD;
        -  To delineate the role of netrin-1, CD146 and MMP2 signaling pathway in the progression&#xD;
           of invasion of placenta accrete spectrum.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>impact of netrin-1 in the pathophysiology of placenta accreta spectrum</measure>
    <time_frame>baseline</time_frame>
    <description>Estimation of local placental netrin-1 protein expression by immunohistochemistry , 4. Estimation of local placental expression of CD146 in tissue homogenate, 5. Estimation of local placental expression of MMP-2 in tissue homogenate.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Pathophysiology of Placenta Accreta</condition>
  <arm_group>
    <arm_group_label>group A</arm_group_label>
    <description>group A : placental tissue of 30 patients with placenta accreta</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group B</arm_group_label>
    <description>group B : placental tissue of 20 normal pregnancy as a control group</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        1. Full history taking including currant age, age of marriage, parity, history of&#xD;
             abortion , history of dilation and endometrial curettage(D&amp;C), number of previous&#xD;
             caesarian section, history of uterine congenital anomaly, postpartum endometritis,&#xD;
             hysteroscopic surgery, previous abnormal placentation, and similar condition in the&#xD;
             family.&#xD;
&#xD;
          2. Estimation of body mass index (BMI). 3- placental tissue obtained after delivery for&#xD;
             immunohistochemistry and tissue homogenate analysis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ages between 20 to 40 years will be included.&#xD;
&#xD;
          -  Gestational age: between 34 to 38 weeks.&#xD;
&#xD;
          -  History of previous cesarean sections.&#xD;
&#xD;
          -  Ultrasonographic findings suggestive PAS according to Jauniaux et al. (2018) :&#xD;
&#xD;
               -  Loss of the retro-placental clear zone.&#xD;
&#xD;
               -  Thinning of myometrium.&#xD;
&#xD;
               -  Abnormal placental lacunae.&#xD;
&#xD;
               -  Bladder wall interruption.&#xD;
&#xD;
               -  Placental bulge.&#xD;
&#xD;
               -  Exophytic placental mass.&#xD;
&#xD;
          -  Doppler findings suggestive PAS according to Jauniaux et al. (2018):&#xD;
&#xD;
               -  Subplacental hypervascularity.&#xD;
&#xD;
               -  Uterovesical hypervascularity/bridging vessels.&#xD;
&#xD;
               -  Vascular lacunae with turbulent flow/feeder vessels.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Fundal and middle anterior or posterior placenta.&#xD;
&#xD;
        â€¢ Pregnancy associated with morbid conditions as: hypertension, diabetes mellitus,&#xD;
        autoimmune disease, cardiac disease, renal disease, and endocrinal disease.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>hanaa mohammed mohammed sayed, assistant lecturer</last_name>
    <phone>01016113232</phone>
    <email>hanaa.dwak@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>heba mahmoud iraqy, lecturer</last_name>
    <phone>01099073405</phone>
    <email>dr.heba20@yahoo.com</email>
  </overall_contact_backup>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 9, 2020</study_first_submitted>
  <study_first_submitted_qc>November 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2020</study_first_posted>
  <last_update_submitted>November 9, 2020</last_update_submitted>
  <last_update_submitted_qc>November 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Hanaa Mohammed Mohammed Sayed</investigator_full_name>
    <investigator_title>assistant lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Placenta Accreta</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

